Detalhe da pesquisa
1.
Small Cell Lung Cancer in Light/Never Smokers - A Role for Molecular Testing?
J Natl Compr Canc Netw
; 21(4): 336-339, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791749
2.
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 375(19): 1823-1833, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718847
3.
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Lancet Oncol
; 18(12): 1600-1609, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129441
4.
Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice.
J Natl Compr Canc Netw
; 14(3): 291-8, 2016 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26957615
5.
Trajectories of Health Care Contact Days for Patients With Stage IV Non-Small Cell Lung Cancer.
JAMA Netw Open
; 7(4): e244278, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587847
6.
Is cancer stage data missing completely at random? A report from a large population-based cohort of non-small cell lung cancer.
Front Oncol
; 13: 1146053, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081984
7.
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.2.
J Clin Oncol
; 41(24): e63-e72, 2023 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433095
8.
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2.
J Clin Oncol
; 41(5): e1-e9, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534935
9.
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2.
J Clin Oncol
; 41(5): e10-e20, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534938
10.
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
J Clin Oncol
; 41(11): 1999-2006, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735893
11.
Use of imaging for active surveillance in testicular cancer: Is real-world practice concordant with guidelines?
Can Urol Assoc J
; 16(2): 26-33, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34582333
12.
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.
J Clin Oncol
; 40(28): 3310-3322, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816666
13.
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
J Clin Oncol
; 40(28): 3323-3343, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816668
14.
Treatment and Patient Selection for Patients with Metastatic Castration-resistant Prostate After Progression on Docetaxel and Abiraterone/Enzalutamide: When to Play Your CARD and When to Do Your PARP.
Eur Urol
; 80(2): 123-126, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773874
15.
Patient perspectives of value of delayed disease progression on imaging (imaging PFS). A treatment trade-off experiment.
J Cancer Policy
; 30: 100301, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35559797
16.
A Systematic Review and Meta-analysis of Dual Therapy in Patients With Advanced Renal Cell Carcinoma of Favourable Risk.
Urology
; 157: 8-14, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461142
17.
Quality of End-of-Life Care for People with Advanced Non-Small Cell Lung Cancer in Ontario: A Population-Based Study.
Curr Oncol
; 28(5): 3297-3315, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590598
18.
Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort Study.
J Clin Oncol
; 39(7): 779-786, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507821
19.
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50.
J Clin Oncol
; 39(21): 2339-2349, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872070
20.
Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042.
JTO Clin Res Rep
; 2(8): 100205, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590048